Stock

LifeMD, Inc. LFMD

$4.25+1.19%

All stocks Create account to unlock

Overview

LFMD market data

Price History

LFMD price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for LFMD. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

3 captured

LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection · Jun 22, 2026, 12:15 PM

LifeMD To Launch Program For XYOSTED Injection · Jun 22, 2026, 12:15 PM

HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $10 Price Target · May 26, 2026, 4:36 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock